BMS-936564

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-936564, covering 2016-03-16 to 2016-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1]

See pricing